Latest Research & News

Parkinson’s disease is a progressive neurological disorder that primarily affects movement, but its impact extends far beyond motor control. First described in 1817 by the British physician James Parkinson, the condition has since become one of the most studied neurodegenerative diseases in the world. Despite extensive research, it remains incurable, though treatments can significantly improve quality of life. Understanding Parkinson’s disease requires examining its causes, symptoms, progression, and the ongoing efforts to manage and eventually cure it. At its core, Parkinson’s disease is caused by the gradual degeneration of neurons in a specific area of the brain called the substantia nigra. These neurons are responsible for producing dopamine, a neurotransmitter that plays a crucial role in coordinating movement and emotional responses. As dopamine levels decline, the brain’s ability to regulate movement becomes impaired, leading to the hallmark symptoms of the disease. While the exact cause of neuronal degeneration is not fully understood, a combination of genetic and environmental factors is believed to contribute. The symptoms of Parkinson’s disease are typically divided into: - Motor symptoms include tremors, muscle rigidity, slowness of movement (bradykinesia), and impaired balance or posture. Tremors often begin in one hand or limb and may spread as the disease progresses. Muscle stiffness can make everyday tasks, such as walking or dressing, increasingly difficult. Over time, patients may develop a shuffling gait and experience frequent falls. - Non-motor symptoms can be equally, if not more, debilitating. These include depression, anxiety, sleep disturbances, cognitive decline, and autonomic dysfunction (such as problems with blood pressure regulation or digestion). DIAGNOSIS The progression of Parkinson’s disease varies widely among individuals. In its early stages, symptoms may be mild and barely noticeable. As the disease advances, symptoms become more pronounced and can significantly interfere with daily life. In later stages, patients may require assistance with basic activities such as eating, bathing, and walking. Diagnosis of Parkinson’s disease is primarily clinical, meaning it is based on medical history and physical examination rather than a definitive laboratory test. Neurologists look for characteristic symptoms and may use imaging techniques to rule out other conditions. Early and accurate diagnosis is essential for effective management, although it can be challenging in the initial stages. TREATMENTS AND MEDICATION Treatment for Parkinson’s disease focuses on managing symptoms, as there is currently no cure. The most commonly used medication is levodopa, which is converted into dopamine in the brain and helps alleviate motor symptoms. Other medications, such as dopamine agonists, are also used to enhance dopamine function. While these treatments can be highly effective, their benefits may diminish over time, and long-term use can lead to side effects such as involuntary movements. In addition to medication, non-pharmacological approaches play a vital role in managing the disease. Physical therapy can help maintain mobility and balance, while occupational therapy assists patients in adapting to daily challenges. Speech therapy may be necessary for those experiencing difficulties with communication or swallowing. Regular exercise has been shown to improve both motor and non-motor symptoms, highlighting the importance of an active lifestyle. ONGOING RESEARCH Research into Parkinson’s disease is ongoing and multifaceted. Scientists are exploring the underlying mechanisms of neuronal degeneration, including the role of protein misfolding and inflammation. Advances in genetics have identified several genes associated with an increased risk of developing the disease. Additionally, researchers are investigating potential disease-modifying therapies that could slow or halt progression, rather than simply treating symptoms. One promising area of research involves stem cell therapy, which aims to replace damaged neurons with healthy ones. Another focuses on developing drugs that target alpha-synuclein, a protein that accumulates abnormally in the brains of individuals with Parkinson’s disease. While these approaches are still largely experimental, they offer hope for more effective treatments in the future. Living with Parkinson’s disease presents significant physical, emotional, and social challenges. Patients often require strong support systems, including family, caregivers, and healthcare professionals. Education and awareness are essential for reducing stigma and ensuring that individuals receive appropriate care and understanding. CONCLUSIONS Parkinson’s disease is a complex and multifaceted condition that affects millions of people worldwide. Although it is primarily known for its impact on movement, its effects are far-reaching and deeply influence quality of life. While current treatments can manage symptoms effectively, the search for a cure continues. Ongoing research and advances in medical science provide hope that one day, Parkinson’s disease may be not only treatable but preventable or even curable.

“Disease is very old, and nothing about it has changed. It is we who change as we learn to recognize what was formerly imperceptible.” - Jean-Martin Charcot In 1868, a mysterious neurological condition finally received a name. The French neurologist Jean-Martin Charcot described and classified a disease he called la sclérose en plaques. Often regarded as the “Father of Neurology”, Charcot was the first to recognize this disorder as a distinct medical entity. The condition would later become known in English medical literature as Multiple Sclerosis (MS) [1]. Yet the story of MS did not begin with Charcot. Descriptions resembling the disease appear in medical writings dating as far back as the Middle Ages. What had been missing, however, was the scientific framework needed to connect symptoms observed in living patients with structural changes in the nervous system. The nineteenth century brought exactly that shift: physicians began pairing clinical observation with pathological anatomy. This methodological breakthrough allowed Charcot to link patients’ neurological symptoms with distinctive lesions - scattered sclerotic plaques - found in the brain and spinal cord during post-mortem examination [2][3]. From these observations emerged what is now known as Charcot’s triad, a set of hallmark symptoms that helped physicians recognize the disease. These include nystagmus, involuntary rhythmic eye movements; intention tremor, which appears during voluntary motion; and scanning speech, a distinctive form of dysarthria in which words are pronounced slowly and broken into syllables. Modern neuroscience has greatly expanded upon Charcot’s early insights. Today, multiple sclerosis is understood as a chronic autoimmune, neuroinflammatory, and neurodegenerative disorder affecting the central nervous system (CNS) [4]. Although decades of research have significantly advanced our knowledge, the precise causes of MS remain complex and not fully understood. What is clear, however, is the central role of demyelination - the destruction of the myelin sheath, the insulating layer that surrounds nerve fibers in the white matter of the brain and spinal cord [5]. Because myelin enables rapid and efficient electrical signaling between neurons [6], its degradation disrupts communication within the nervous system and can lead to a wide range of neurological symptoms, including impaired motor control. Historically, identifying MS was far from straightforward. The disease’s polymorphic presentation often led physicians to confuse it with other neurological conditions, particularly Parkinson’s disease, which had been described decades earlier under the name paralysis agitans. Both disorders could involve tremors and motor disturbances, making differentiation difficult. One of Charcot’s earliest and most influential cases involved his female servant, Luc, who had initially been diagnosed with shaking palsy. Through careful observation, Charcot noticed something unusual about her symptoms. Unlike Parkinsonian tremors, which occur continuously, Luc’s tremors appeared primarily during intentional movements. This subtle difference raised an important question: was this truly the same disease? The answer emerged after Luc’s death. During the post-mortem examination of her brain and spinal cord, Charcot identified distinctive sclerotic plaques distributed throughout the central nervous system. These lesions confirmed that the disorder he was observing was not Parkinson’s disease, but a separate and previously unrecognized neurological pathology [3]. Much of this pioneering work took place at the Hôpital de la Salpêtrière in Paris, where Charcot worked alongside his colleague Alfred Vulpian. Together, they helped define multiple sclerosis as a distinct clinical entity. Their early observations highlighted the severe prognosis associated with the disease and the widespread lesions found throughout the nervous system - features that remain central to MS diagnosis today. They also recognized something that continues to challenge neurologists even now: MS rarely presents the same way twice. Because lesions can appear in different regions of the central nervous system - spinal, cerebral, or both - the symptoms can vary widely between patients. This variability is one of the defining characteristics of multiple sclerosis and remains a key challenge in both diagnosis and treatment. These early discoveries laid the foundation for more than a century of neurological research. From Charcot’s first observations of mysterious plaques in the nervous system to today’s advanced imaging techniques and molecular studies, our understanding of multiple sclerosis has evolved tremendously. Yet many questions remain unanswered. Despite significant therapeutic progress, MS continues to be an incurable and highly complex disease. Understanding its mechanisms - from immune dysregulation to demyelination and neurodegeneration - remains one of the central challenges of modern neuroscience, and a crucial step toward developing treatments that can not only slow the disease but ultimately repair the damage it causes. Bibliography: 1. B. Zalc. One hundred and fifty years ago Charcot reported multiple sclerosis as a new neurological disease. Brain. Vol. 141, Issue 12, pg. 3482-3488, 2018, https://pmc.ncbi.nlm.nih.gov/articles/PMC6262215/. 2. Harvard Medical School Library - Countway Library of Medicine. Medical treatment in the nineteenth-century. Apothecary Jars Exhibit. https://collections.countway.harvard.edu/onview/exhibits/show/apothecary-jars/nineteenth-century-treatment. 3. Z. G. Reyes. Sclérose en Plaques: A Tribute to the History of Multiple Sclerosis and Charcot’s Role in Precision Medicine Today. American Academy of Neurology Medical Student Essay Award. 2023, https://www.aan.com/siteassets/home-page/education-and-research/research/award-winners/scientific-award-winners/2023-winners/reyes_zabrina_medical_student_essay.pdf. 4. A. H. Maghzi, A. Borazanci, J. McGee, J. S. Alexander, E. Gonzalez-Toledo, A. Minagar. 1 - Multiple Sclerosis: Pathophysiology, Clinical Features, Diagnosis, and Management. Neuroinflammation. pg. 1-23, 2011, https://www.sciencedirect.com/science/chapter/edited-volume/abs/pii/B9780123849137000010?via%3Dihub. 5. J. M. Greer, P. A. McCombe. Role of gender in multiple sclerosis: Clinical effects and potential molecular mechanisms. Journal of Neuroimmunology, vol. 234, issues 1-2, pg. 7-18, 2011, https://www.sciencedirect.com/science/article/abs/pii/S0165572811000658. 6. P. Morell, W. T. Norton. Myelin. Scientific American, vol. 242, no.5 (May 1980), pg. 88-119, https://www.jstor.org/stable/24966326.

What Is Sunscreen? Sunscreen is a product applied to the skin to safeguard it from the sun’s harmful rays. It works by blocking or reducing ultraviolet (UV) radiation so that it does not damage the skin. The sun emits UV radiation, an invisible type of light that can be harmful. Two types are particularly important: UVB and UVA rays. UVB rays cause sunburn and contribute to skin cancer, while UVA rays affect deeper skin layers, leading to skin aging, such as wrinkles and dark spots, and also contribute to skin diseases. Most sunscreen products display an SPF number, which indicates how well they protect the skin against UVB rays. Although no sunscreen can block all UV radiation, proper use provides significant protection and helps prevent sunburn and skin damage. Why Is Sunscreen Important? Sunscreen helps prevent sunburn and preserve the integrity of the skin. In addition, it reduces the risk of skin cancer and slows down premature skin aging, making it an essential part of daily skin care. Strategies to Reduce Sun Damage To diminish sun-related skin damage, it is recommended to use a broad-spectrum sunscreen with an SPF of at least 30, applied 15–30 minutes before sun exposure. It is essential to reapply every two hours and ensure that all exposed areas, including the face, ears, neck, hairline, and arms, are covered. Combining sunscreen with protective clothing, hats, and seeking shade further enhances skin protection.

Many important medical discoveries were made thanks to chance, curiosity, and careful observation. In some cases, scientists did not get the results they expected, but instead of ignoring them, they chose to investigate further. These moments changed the course of medicine. One of the most famous examples is penicillin. In 1928, Alexander Fleming noticed that a mold called Penicillium had grown in one of his Petri dishes and killed the bacteria around it. Although this happened by accident, Fleming understood its importance. This discovery later led to the development of antibiotics, which have saved millions of lives by treating bacterial infections. Another important discovery is related to anticoagulants. Chemist Karl Paul Link began studying cases in which cattle were bleeding without an obvious reason after eating moldy clover. His research helped identify substances that prevent blood from clotting. Even though these substances were first used as rat poison, they were later adapted for medical use and are now essential in treating heart diseases and preventing strokes. Some medical inventions were also the result of technical mistakes. The pacemaker is a good example. While early versions were created by Rune Elmqvist and Åke Senning, Wilson Greatbatch later improved the device after accidentally building an incorrect electrical circuit. He realized that the device could control heartbeats. In 1960, the first pacemaker was successfully implanted in a human patient, helping people with heart rhythm problems live longer lives. Another major breakthrough in medicine was anesthesia. In the 19th century, Horace Wells observed that substances such as nitrous oxide and ether could reduce pain. Although his early attempts at painless dental procedures were not successful, the idea continued to develop. William Morton later proved that anesthesia worked, making modern surgery possible and greatly reducing pain during medical procedures. These examples show that progress in medicine does not always come from perfect planning, but often from curiosity and the ability to learn from unexpected situations.